Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page now indicates that recruitment has ended, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) alongside a revision tag update from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page shows Revision: v3.5.5 (replacing v3.5.4), indicating a minor platform update that does not change the study details or data on this page.SummaryDifference0.0%

- Check37 days agoChange DetectedA new revision label, Revision: v3.5.4, was added and the previous label Revision: v3.5.3 was removed. This update reflects a version history change on the site’s release notes.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s footer/version indicator has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a site update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check65 days agoChange DetectedKrakow, Lesser Poland Voivodeship, Poland, 30-149 was replaced with Cracow, Lesser Poland Voivodeship, Poland, 30-149. The page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site records.SummaryDifference0.0%

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.